Amgen 2000 Annual Report Download - page 26

Download and view the complete annual report

Please find page 26 of the 2000 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 47

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47

29
Consolidated Balance Sheets
(In millions, except per share data)
December 31, 2000 1999
Assets
Current assets:
Cash and cash equivalents $ 226.5 $ 130.9
Marketable securities 1,801.6 1,202.1
Trade receivables, net of allowance for doubtful
accounts of $21.2 in 2000 and $26.0 in 1999 389.2 412.2
Inventories 305.2 184.3
Other current assets 214.6 135.8
Total current assets 2,937.1 2,065.3
Property, plant and equipment at cost, net 1,781.5 1,553.6
Other assets 681.0 458.7
$ 5,399.6 $ 4,077.6
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable $ 143.2 $ 83.4
Commercial paper 99.7 99.5
Accrued liabilities 619.2 648.2
Total current liabilities 862.1 831.1
Long-term debt 223.0 223.0
Stockholders’ equity:
Preferred stock; $0.0001 par value; 5.0 shares authorized;
none issued or outstanding ——
Common stock and additional paid-in capital; $0.0001 par value;
2,750.0 shares authorized; outstanding - 1,037.4 shares in
2000 and 1,017.9 shares in 1999 2,947.3 2,072.3
Retained earnings 1,304.6 966.0
Accumulated other comprehensive income (loss) 62.6 (14.8)
Total stockholders’ equity 4,314.5 3,023.5
$ 5,399.6 $ 4,077.6
See accompanying notes.